Determinants of severe hypoglycemia complicating type 2 diabetes: The Fremantle diabetes study

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2240-2247

  Davis, Timothy M E ^a   Brown, Simon G A ^b   Jacobs, Ian G ^b   Bulsara, Max ^c   Bruce, David G ^a   Davis, Wendy A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY SAMPLE; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; KIDNEY DYSFUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; EMERGENCY; HOSPITALIZATION; INCIDENCE; POISSON DISTRIBUTION; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; STATISTICS;

DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; EMERGENCIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; MALE; POISSON DISTRIBUTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 77952766075     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2828     Document Type: Article

References (30)

1. Amiel SA, Dixon T, Mann R, Jameson K 2008 Hypoglycaemia in type 2 diabetes. Diabet Med 25:245-254
2. UKPDS Group 1998 Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
3. UK Hypoglycaemia Study Group 2007 Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50:1140-1147
4. UKPDS Group 1983 U.K. Prospective Diabetes Study I: effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year. Diabetologia 24:404-411
5. Murad MH, Coto-Yglesias F, Wang AT, Sheidaee N, Mullan RJ, Elamin MB, Erwin PJ, Montori VM 2009 Clinical review: drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 94:741-745
6. Murata GH, Duckworth WC, Hoffman RM, Wendel CS, Mohler MJ, Shah JH 2004 Hypoglycemia in type 2 diabetes: a critical review. Biomed Pharmacother 58:551-559
7. American Diabetes Association (ADA) Workgroup on Hypoglycaemia 2005 Defining and reporting hypoglycaemia in diabetes. Diabetes Care 28:1245-1249
8. Canadian Diabetes Association (CDA) Clinical Practice Guidelines Expert Committee 2003 Hypoglycemia. Can J Diabetes 27:S43-S45
9. European Agency for Evaluation of Medicinal Products (EMEA) 2002 Note for guidance on clinical investigation of medicinal products in the treatment of diabetes mellitus. http://www.ema.europa.eu/pdfs/human/ewp/108000en.pdf
10. Bulsara MK, Holman CD, Davis EA, Jones TW 2004 Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies-what method should we use? Diabet Med 21:914-919
11. Davidson JA, Liebl A, Christiansen JS, Fulcher G, Ligthelm RJ, Brown P, Gylvin T, Kawamori R 2009 Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis. Clin Ther 31:1641-1651
12. Mullins P, Sharplin P, Yki-Jarvinen H, Riddle MC, Haring HU 2007 Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus. Clin Ther 29:1607-1619
13. Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR 2000 Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 17:667-674
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470 (Pubitemid 29135798)
15. Norman PE, Davis WA, Bruce DG, Davis TM 2006 Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 29:575-580
16. Holman CD, Bass AJ, Rouse IL, Hobbs MS 1999 Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 23:453-459
17. Vuong QH 1989 Likelihood ratio tests for model selection and nonnested hypotheses. Econometrica 57:307-333
18. Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, Frier BM, Morris AD 2003 Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26:1176-1180
19. Holstein A, Plaschke A, Egberts EH 2003 Clinical characterisation of severe hypoglycaemia - a prospective population-based study. Exp Clin Endocrinol Diabetes 111:364-369
20. Henderson JN, Allen KV, Deary IJ, Frier BM 2003 Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 20:1016-1021
21. Akram K, Pedersen-Bjergaard U, Borch-Johnsen K, Thorsteinsson B 2006 Frequency and risk factors of severe hypoglycemia in insulintreated type 2 diabetes: a literature survey. J Diabetes Complications 20:402-408 (Pubitemid 44740218)
22. Cryer PE 2008 The barrier of hypoglycemia in diabetes. Diabetes 57:3169-3176
23. Stephenson JM, Kempler P, Perin PC, Fuller JH 1996 Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study. Diabetologia 39:1372-1376
24. Freeman R 2005 Autonomic peripheral neuropathy. Lancet 365: 1259-1270
25. Durán-Nah JJ, Rodríguez-Morales A, Smitheram J, Correa-Medina C 2008 Risk factors associated with symptomatic hypoglycemia in type 2 diabetes mellitus patients. Rev Invest Clin 60:451-458
26. Sarkar U, Schillinger D 2008 Does lower diabetes-related numeracy lead to increased risk for hypoglycemic events? Ann Intern Med 149:594
27. Bruce DG, Davis WA, Cull CA, Davis TM 2003 Diabetes education and knowledge in patients with type 2 diabetes from the community: the Fremantle Diabetes Study. J Diabetes Complications 17:82-89
28. Davis WA, Davis TM, Knuiman MW, Hendrie D 2004 Socioeconomic determinants of the distribution of diabetes-attributable direct health care expenditure: the Fremantle Diabetes Study. Diabetologia 47(Suppl 1):A50
29. Bonds DE 2009 Predictors of hypoglycemia and its association with mortality. 69th Scientific Sessions: American Diabetes Association. Cited December 2009. Available from: http://professional.diabetes.org/presentations- details.aspx?session=3381
30. Leckie AM, Graham MK, Grant JB, Ritchie PJ, Frier BM 2005 Frequency, severity, and morbidity of hypoglycemia occurring in the workplace in people with insulin-treated diabetes. Diabetes Care 28:1333-1338